ClinicalTrials.Veeva

Menu

Vitamin D Replacement After Kidney Transplant

University of Nebraska logo

University of Nebraska

Status

Completed

Conditions

Kidney Transplantation
Vitamin D Deficiency

Treatments

Dietary Supplement: Standard vitamin D3 treatment
Dietary Supplement: High dose vitamin D3 treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT00748618
0382-08-FB

Details and patient eligibility

About

Vitamin D deficiency accelerates vascular risk progression after kidney transplant.

Full description

This trial will assess the following aims:

  1. Time to plateau vitamin D concentrations after initiating vitamin D supplements
  2. Safety of vitamin D replacement based on serum and urine calcium
  3. Effect of vitamin D on PTH concentration in individuals with elevated parathyroid hormone
  4. Effect of vitamin D on markers of insulin resistance and inflammation

Enrollment

116 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Kidney transplant more than 6 months ago
  • 19 years or older
  • 25-hydroxy vitamin D ≤35 ng/ml

Exclusion criteria

  • Estimated Glomerular filtration rate (GFR) <30 ml/min/1.73m²
  • Previous small bowel or lung transplant
  • Pancreas transplant less than 6 months ago
  • Cancer or any condition that would change their weight dramatically in the near future such as malabsorption
  • Willing to return for testing every two months
  • Women who are pregnant or < 6 weeks postpartum
  • Calcium > 10.5 mg/dl
  • Phosphate > 4.8 mg/dl
  • Drinking more than 2 alcohol drinks a day or 14 drinks per week
  • History of parathyroid surgery
  • Known granulomatous disease
  • Taking any seizure medication that affects vitamin D
  • Taking Zemplar ® and/or Rocaltrol ®
  • History of kidney stones in the past 20 years
  • Not on a stable dose of bisphosphonate for the past three months
  • Planning on a pancreas transplant within the next year
  • In any other research study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

116 participants in 2 patient groups

Standard vitamin treatment
Other group
Description:
10,000 I.U. of vitamin D3 weekly
Treatment:
Dietary Supplement: Standard vitamin D3 treatment
50,000 I.U. of vitamin D3
Active Comparator group
Description:
50,000 I.U. of vitamin D3 weekly
Treatment:
Dietary Supplement: High dose vitamin D3 treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems